GB9914057D0 - Antibody therapy - Google Patents
Antibody therapyInfo
- Publication number
- GB9914057D0 GB9914057D0 GBGB9914057.6A GB9914057A GB9914057D0 GB 9914057 D0 GB9914057 D0 GB 9914057D0 GB 9914057 A GB9914057 A GB 9914057A GB 9914057 D0 GB9914057 D0 GB 9914057D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibody therapy
- antibody
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6815—Enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9914057.6A GB9914057D0 (en) | 1999-06-16 | 1999-06-16 | Antibody therapy |
AU54157/00A AU5415700A (en) | 1999-06-16 | 2000-06-16 | Emzyme-assisted cell death |
PCT/GB2000/002351 WO2000076453A2 (en) | 1999-06-16 | 2000-06-16 | Emzyme-assisted cell death |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9914057.6A GB9914057D0 (en) | 1999-06-16 | 1999-06-16 | Antibody therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9914057D0 true GB9914057D0 (en) | 1999-08-18 |
Family
ID=10855492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9914057.6A Ceased GB9914057D0 (en) | 1999-06-16 | 1999-06-16 | Antibody therapy |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5415700A (en) |
GB (1) | GB9914057D0 (en) |
WO (1) | WO2000076453A2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8528761D0 (en) * | 1985-11-22 | 1985-12-24 | Axon Healthcare Ltd | Enzyme-coupled antibodies |
-
1999
- 1999-06-16 GB GBGB9914057.6A patent/GB9914057D0/en not_active Ceased
-
2000
- 2000-06-16 WO PCT/GB2000/002351 patent/WO2000076453A2/en active Application Filing
- 2000-06-16 AU AU54157/00A patent/AU5415700A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000076453A2 (en) | 2000-12-21 |
AU5415700A (en) | 2001-01-02 |
WO2000076453A3 (en) | 2001-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1200316A1 (en) | Therapeutic microfoams | |
GB9911863D0 (en) | Therapeutic agents | |
GB9905010D0 (en) | Therapeutic agents | |
GB9911569D0 (en) | Antibodies | |
GB0028429D0 (en) | Therapy | |
GB9909064D0 (en) | Therapies | |
GB9904786D0 (en) | Therapeutic agents | |
GB9903584D0 (en) | Modified calycins | |
GB9930570D0 (en) | Therapy | |
GB9911881D0 (en) | Therapeutic agents | |
GB9907243D0 (en) | Therapy | |
GB9816556D0 (en) | Therapy | |
GB9911802D0 (en) | Therapeutic combination | |
GB9903476D0 (en) | Therapeutic agents | |
GB9911803D0 (en) | Therapeutic combination | |
GB9911804D0 (en) | Therapeutic combination | |
GB9903119D0 (en) | Therapeutic agents | |
EP1170018A4 (en) | Ligand-bonded complex | |
GB9914742D0 (en) | Therapeutic agents | |
GB9902881D0 (en) | Therapeutic agents | |
GB9915419D0 (en) | Antigens | |
GB9914057D0 (en) | Antibody therapy | |
GB9927698D0 (en) | Therapeutic antibody | |
GB9915616D0 (en) | Therapeutic agents | |
GB9929923D0 (en) | Antigen preparations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |